Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)

Market Cap	2.65B -35.1%
Revenue (ttm)	359.10M +6.1%
Net Income	23.32M +16.5%
EPS	0.20 +15.9%
Shares Out	119.98M
PE Ratio	110.16
Forward PE	n/a
Dividend	0.13 (0.58%)
Ex-Dividend Date	Sep 22, 2026

Volume	1,155,500
Open	23.21
Previous Close	22.12
Day's Range	21.81 - 23.21
52-Week Range	16.38 - 37.59
Beta	1.16
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 28, 2026

About SHE:300813

Zhejiang Tailin BioEngineering Co.,Ltd engages in the research and development, production, and sale of microbial detection, contamination control, process analysis, and inhibition protection in the life sciences field in China and internationally. The company primarily offers aseptic production and contamination control equipment, microbial testing products, and organic matter analysis technology products. It also provides pharma processing, such as pharma isolators, high-precision filling and dispensing, sterile transfer; cell and gene therap...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Employees: 790
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300813

Financial Performance

In 2025, SHE:300813's revenue was 339.54 million, a decrease of -2.71% compared to the previous year's 349.00 million. Earnings were 16.49 million, an increase of 26.32%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 29, 2026

Data Sources Report a data error